7th Annual Pulmonary Embolism Symposium

October 14-16, 2021 / Presented Virtually


The PERT Consortium® was formed to promote best practices in Pulmonary Embolism (PE) care. By focusing solely on the entirety of PE – its etiology, pathophysiology, prevention, management approach, outcomes of specific treatments, and follow-up pathways – it is the intention of the Consortium to increase awareness of treatment options available to patients with PE, to reduce its incidence worldwide, to improve health outcomes, and to positively influence the impact of this terrible disease.

This annual two-day, AMA PRA/ANCC‐accredited conference entitled, Pulmonary Embolism: What is Known, and What We Need to Know: A State of the Art and Scientific Update, is designed for practicing clinicians who regularly care for patients with acute and chronic pulmonary embolism (PE), as well as those who are interested in studying the pathophysiology, epidemiology, diagnosis, prevention, medical and interventional management, novel treatment paradigms, and outcomes of pulmonary embolism (PE).  The meeting agenda has been expanded to include topics and presentations surrounding COVID-19 and the unique association of this virus with Venous Thromboembolic Disease (VTE), and specifically its impact on incidence, diagnosis and unique management strategies of Pulmonary Embolism.

This meeting will be completely in virtual format.




Vendor Resources


Download Vendor
Support Prospectus
Download Vendor
Application Form



This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and PERT Consortium. Boston University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 15 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity has been provided by  Boston University School of Medicine Continuing Nursing Education and jointly-provided by PERT Consortium.
Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation


This program is supported by educational grants from:

  • Abiomed
  • Boston Scientific
  • Cook Medical
  • Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC
  • Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance

Program Overview

Day 1: Thursday, October 14
12:30-2:00 PM
Business Meeting
Day 2: Friday, October 15
7:00 - 8:00 AM
Welcoming Remarks
State of PE in 2021 and Role of the PERT Consortium
Clive Kearon Inaugural Address
Impactful Papers since PERT 2020
8:00 - 9:00 AM
Epidemiology and Demographics
Global Impact of PE And Differences Between US, Europe, Africa, and Asia PE In the Out of Hospital Population and Hospital Acquired PE: Scope Of The Problem
ESC Guidelines - What Has Changed and Why? What Can We Anticipate for Future Guidelines?
9:00 - 10:00 AM
Diagnosis of PE
Clinical Evaluation and Biochemical Markers
Update on Imaging in 2021 - CT and Beyond
ECHO and the Danger of the Right Ventricle
AI and PE: Coming to a PERT near you?
10:00 - 10:30 AM
10:00 - 11:30 AM
A - IVC Filter: Successes, Failures and Controversies
B - POCUS – Echo in PE
C - Where are the Data? It Might Be Here: Trials and Registries in PE and VTE
11:30 AM - 1:30 PM
Lunch Session & Industry Satellite
1:30 - 2:30 PM
Post PE Follow Up and Care
Survivorship in PE: What to Follow and How to Follow our Patients
CTED vs. CTEPH vs. PTSD: Unravelling the Gordon Knot
Through Thick and Thin - Risk of Recurrent Clotting Versus Bleeding
2:30 -3:30 PM
High Risk PE:
Cases that raise your blood pressure and what to do about them
3:30 - 4:30 PM
Intermediate Risk PE Panel Discussion
4:30 - 5:30 PM
Low Risk PE Panel Discussion
Day 3: Saturday, October 16
8:00 - 9:00 AM
Pathogenesis and Epidemiology
9:00 - 10:00 AM
Surgical Patients
Medical Patients
Cancer Patients
10:00 - 11:00 AM
Regulatory Pathways and Hurdles in Pulmonary Embolism Management
How Does the Regulatory Environment Affect What I can Offer My Patients; Practicing Clinicians’ Perspectives
PERT Consortium Registry
11:00 - 11:30 AM
11:30 AM - 12:30 PM
A – Mechanical Support
B – PERT Teams
C - Innovations in PE Management; New Devices and Concepts
12:30 - 2:30 PM
Lunch Session & Industry Satellite
2:30 - 3:30 PM
Bleeding Cases to Make You Think Twice
Heparin/LMWH, VKA, Thrombolytics
Bleeding Management Beyond Reversal
3:30 - 4:30 PM
Surgical Management
4:30 - 5:30 PM
RV Failure and Pulmonary Infarction
Tumor Thromboembolism

Program Course Directors

Emily Gundert
MD FAAEM, University of Texas Southwestern Dallas, TX
Menno Huisman
MD, PhD, FESC Leiden University Medical Center Leiden, the Netherlands
Scott Kaatz
DO, MSc, FACP, SFHM Henry Ford Hospital Detroit, MI
John Moriarty
MD FSIR UCLA Medical Center Los Angeles, CA


Vikas Aggarwal
MD - University of Michigan Medical School
William Auger
MD - UC San Diego
Geoff Barnes
MD - MSc University of Michigan
Sonja Bartolome
MD - UT Southwestern
Allison Burnett
PharmD, PhC, CACP - New Mexico College of Pharmacy
Richard Channick
MD - David Geffen School of Medicine at UCLA
Jean Connors
MD - Harvard Medical School Brigham and Women's Dana Farber
Mahir Elder
MD - Detroit Medical Center
Oren Friedman
MD - Cedars-Sinai
Jay Giri
MD, MPH - University of Pennsylvania
Joshua Goldberg
MD - Westchester Medical Center NY Medical College
Charles Grodzin
MD - Emory University
Emily Gundert
MD, FAAEM - UT Southwestern
Amy Hackmann
MD - UT Southwestern
Sara Hegab
MD - Henry Ford Health System
Jim Horowitz
Menno Huisman
MD, PhD, FESC - Leiden University Medical Center
Scott Kaatz
DO, MSc, FACP, SFHM - Henry Ford Health System
Christopher Kabrhel
MD, MPH - Massachusetts General Hospital
Brent Keeling
MD - Emory University
Gerald Keoring
MD, PhD - Henry Ford Health System
Alok Khorana
MD - Cleveland Clinic
Andrew Klein
MD, FAAC, FSCAI - Piedmont Healthcare
Jeffrey Kline
MD - Indiana University
Frederikus A (Erik) Klok
MD, PhD - Leiden University Medical Center
Stavros Konstantinides
MD, PhD, FESC, FRCP - Mainz University
Patrick Lawler
MD - Peter Munk Cardiac Centre at University Health Network
Jun Li
MD - University Hospitals of Cleveland
Robert Lookstein
Michael McDaniel
MD, FACC, FSCAI - Emory University
John Moriarity
Tim Morris
MD, FCCP - UC San Diego
Fionnula Ni Ainle
MD, PhD - Mater Misericordiae University Hospital and Rotunda Hospital
Gregory Piazza
MD, MS - Harvard Medical School Brigham and Women's Hospital
Matteo Porres Aguilar
MD - Texas Tech
Ashley Prosper
Parth Rali
MD Temple University
Mona Ranade
MD - Mount Sinai
Belinda Rivera-Lebron
MD, MS, FCCP - University of Pittsburgh Medical Center
Kenneth Rosenfield
MD, MSc - Massachusetts General Hospital
Rachel Rosovsky
MD, MPH - Massachusetts General Hospital
Sam Schulman
MD - McMaster University
Eric Secemsky
MD, MSc, RPVI, FACC, FSCAI, FSCVM - Beth Israel Deaconess Medical Center
Andrew Sharp
MD - University Hospital of Wales
Deborah Siegal
University of Ottawa
Akhi Sista
MD - NYU Langone Health
Roy Smith
MD - University of Pittsburgh Medical Center
Zach Steinberg
MD - UW Medicine
Keith Sterling
MD - Inova
Victor Tapson
MD - Cedars-Sinai Health System
Tom Todoran
MD - MUSC Health
Phillip Wells
MD, FRCP© - The University of Ottawa
Alison Witkin
MD - Massachusetts General Hospital
Cam Wright
MD - Massachusetts General Hospital
Eric Yang

Virtual Meeting

This meeting will be help completely virtual. When you register for the Symposium you will be provided with a login for the virtual event.